English Funding Rejection For Lynparza Triggers Concern Over ‘Double Counting’ Costs

 
• By Neena Brizmohun
  
Male doctor/nurse wearing blue scrubs, with a stethoscope around his neck and holding a Union Jack money purse.
NICE says Lynparza is too expensive for treating prostate cancer • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet